PyInvesting

Market research

WPS.F West Pharmaceutical Services, Inc

F EUR Healthcare

Latest close

366.4 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
24B
P/E ratio
50.61
Analyst target
436
Dividend yield
0.3%
Beta
1.12

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

West Pharmaceutical Services, Inc is currently in a long term uptrend where the price is trading 24.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.0.

West Pharmaceutical Services, Inc's total revenue rose by 23.3% to $580M since the same quarter in the previous year.

Its net income has increased by 54.0% to $98M since the same quarter in the previous year.

Finally, its free cash flow grew by 32.3% to $91M since the same quarter in the previous year.

Based on the above factors, West Pharmaceutical Services, Inc gets an overall score of 5/5.